These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24731550)

  • 1. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.
    Ambrosio MR; Navari M; Di Lisio L; Leon EA; Onnis A; Gazaneo S; Mundo L; Ulivieri C; Gomez G; Lazzi S; Piris MA; Leoncini L; De Falco G
    Infect Agent Cancer; 2014; 9():12. PubMed ID: 24731550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
    Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
    Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
    Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
    Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.
    Navari M; Fuligni F; Laginestra MA; Etebari M; Ambrosio MR; Sapienza MR; Rossi M; De Falco G; Gibellini D; Tripodo C; Pileri SA; Leoncini L; Piccaluga PP
    Front Microbiol; 2014; 5():728. PubMed ID: 25566237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.
    Navari M; Etebari M; De Falco G; Ambrosio MR; Gibellini D; Leoncini L; Piccaluga PP
    Front Microbiol; 2015; 6():556. PubMed ID: 26113842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.
    Lu Y; Qin Z; Wang J; Zheng X; Lu J; Zhang X; Wei L; Peng Q; Zheng Y; Ou C; Ye Q; Xiong W; Li G; Fu Y; Yan Q; Ma J
    J Innate Immun; 2017; 9(6):574-586. PubMed ID: 28877527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus miR-BARTs 7 and 9 modulate viral cycle, cell proliferation, and proteomic profiles in Burkitt lymphoma.
    Caetano BFR; Rocha VL; Rossini BC; Dos Santos LD; Elgui De Oliveira D
    Tumour Virus Res; 2024 Jun; 17():200276. PubMed ID: 38159643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
    Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
    J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types.
    Soltani S; Zakeri A; Tabibzadeh A; Zakeri AM; Zandi M; Siavoshi S; Seifpour S; Farahani A
    Mol Biol Rep; 2021 Feb; 48(2):1801-1817. PubMed ID: 33523370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus.
    Gulley ML; Sargeant KP; Grider DJ; Eagan PA; Davey DD; Damm DD; Robinson RA; Vandersteen DP; McGuff HS; Banks PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Oct; 80(4):425-31. PubMed ID: 8521106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases.
    Mundo L; Ambrosio MR; Picciolini M; Lo Bello G; Gazaneo S; Del Porro L; Lazzi S; Navari M; Onyango N; Granai M; Bellan C; De Falco G; Gibellini D; Piccaluga PP; Leoncini L
    Front Microbiol; 2017; 8():229. PubMed ID: 28298901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.
    Coghill AE; Proietti C; Liu Z; Krause L; Bethony J; Prokunina-Olsson L; Obajemu A; Nkrumah F; Biggar RJ; Bhatia K; Hildesheim A; Doolan DL; Mbulaiteye SM
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):57-62. PubMed ID: 31619404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of EBV in microRNA dysregulation in Burkitt lymphoma.
    De Falco G; Antonicelli G; Onnis A; Lazzi S; Bellan C; Leoncini L
    Semin Cancer Biol; 2009 Dec; 19(6):401-6. PubMed ID: 19619656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency.
    Iizasa H; Wulff BE; Alla NR; Maragkakis M; Megraw M; Hatzigeorgiou A; Iwakiri D; Takada K; Wiedmer A; Showe L; Lieberman P; Nishikura K
    J Biol Chem; 2010 Oct; 285(43):33358-33370. PubMed ID: 20716523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma.
    El-Mallawany NK; Day N; Ayello J; Van de Ven C; Conlon K; Fermin D; Basrur V; Elenitoba-Johnson K; Lim M; Cairo MS
    Eur J Cancer; 2015 Jan; 51(1):92-100. PubMed ID: 25466511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.